Latest / Decera Clinical Education Oncology Podcast
Key Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma
In this episode, Dr Christopher Flowers and Dr John Allan discuss their experience with the use of CD20xCD3 bispecific antibodies in the treatment of patients with relapsed/refractory follicular lymphoma. They also their thoughts on key ongoing clinical trials with bispecific antibodies that they are excited about for their potential to change the standard of care for patients with follicular lymphoma. The overall discussion between these 2 experts includes:
Using bispecific antibodies in clinical practice for relapsed/refractory follicular lymphoma, including an overview of the drugs…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.